Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | Long-term effects of haploidentical transplantation on pulmonary function in patients with SCD

Courtney Fitzhugh • 10 Dec 2022
ASH 2022
Non-Malignant Sickle Cell Disease

In this video, Courtney Fitzhugh, MD, National Institutes of Health, Bethesda, MD, briefly discusses the long-term health effects of haploidentical transplantation in patients with sickle cell disease (SCD), drawing focus on pulmonary function. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Courtney Fitzhugh

2:44
Pentostatin + cyclophosphamide for patients with SCD undergoing haploidentical transplantation
Courtney Fitzhugh • 10 Dec 2022
3:03
Addressing the challenge of secondary malignancies in patients treated for SCD
Courtney Fitzhugh • 10 Dec 2022

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals